Girija is an immunologist working with the organs-on-chips and diagnostics platforms to design better in vitro models of the human immune system and assays to test the performance of immunotherapeutics and vaccines. Her research has come full circle after, as these in vitro models are now informing decision making at pharma and how to create cellular and tissue based therapeutics. Recently, she secured a prestigious Spark contract from ARPA-H Women’s Health Sprint to advance injected lymphoid organs as therapy for ovarian cancer